SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Twos latest earnings and unchanged bookings outlook are in focus alongside strong reported GTA VI preorders and the approaching launch. Traders are split between expecting the blockbuster to drive growth and worrying that cautious guidance, high expectations, or a sell-the-news reaction could weigh on the shares.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

A disappointing Q3 reportmarked by a surprise loss, margin pressure, fewer subscribers sequentially and a reduced profit outlookhas driven HIMSs sharp selloff. Traders are divided between concern over profitability and subscriber momentum and optimism that the Lilly partnership, international expansion and planned peptides offering could support longer-term growth.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 470,841,831.5537221 with 445,839,831.5537221 in circulation. The last known price of Avalanche is 8.67923054 USD and is up 8.47 over the last 24 hours. It is currently trading on 1134 active market(s) with $528,273,140.94 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

Avalanche is drawing attention after reports that the NYSE selected its network for tokenized securities clearing and settlement. Traders are split: some see the institutional tokenization news as bullish, while others say the price reaction faded quickly and question whether adoption will translate into value for AVAX.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is drawing attention as traders react to a broad-market rebound, with some buying the dip or continuing to dollar-cost average into the total-market ETF. Others argue the bounce may be a bull trap, citing concerns about AI-heavy valuations, inflation, energy costs and rising debt.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

A sharp rebound in Coherent shares is drawing attention after quarterly results beat expectations and the outlook strengthened, with traders pointing to AI data-center demand for optical components. Bulls view the prior selloff as overdone, while skeptics remain concerned about broader AI-spending fears and the stocks volatility.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Labs quarterly results are driving attention: revenue and backlog growth and an above-consensus outlook are offset by a wider-than-expected loss, prompting a post-earnings pullback. Bulls point to Iridium-related one-time costs and strong Neutron bookings, while skeptics focus on Neutrons delayed first launch and ongoing execution and profitability risks.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs Q3 earnings are driving attention: traders weigh an EPS beat against a revenue miss tied to lower Bitcoin prices, while debating Bitcoin sales and debt reduction alongside the AI/HPC pivot. Optimists point to a GPU-services contract and the buyback authorization as progress; skeptics focus on the lack of signed tenants at most sites and question whether the pivot can deliver.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Reports of institutional accumulation are fueling renewed interest in CRVS, alongside optimism about soquelitinibs potential across several indications. Bulls point to the pipeline and short interest, while skeptics emphasize the early-stage evidence, delayed updates, and lack of near-term catalysts.

Pepe (PEPE) is a cryptocurrency launched in 2023and operates on the Ethereum platform. Pepe has a current supply of 413,772,350,095,630.40630647. The last known price of Pepe is 0.00000511 USD and is up 0.93 over the last 24 hours. It is currently trading on 729 active market(s) with $552,678,948.79 traded over the last 24 hours. More information can be found at https://www.pepe.vip/.

Pepe

PEPEs sharp, volatile rebounds and periods of strength versus Bitcoin and other major tokens are driving attention, with traders framing the moves as renewed meme-coin momentum or a possible breakout. Bullish calls for more upside and a short squeeze compete with skepticism that rallies will fade and the token will remain range-bound.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A quarterly earnings beat, stronger-than-expected Q4 guidance, and expanded buyback authorization drove a sharp rally, but shares gave back much of the after-hours surge during managements call. Traders debated whether the results signal a turnaround or a short squeeze, with skeptics citing weak underlying growth, margin pressure, and doubts about management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Elon Musk Once Said Psychedelics Could Help PTSD  Now FDA Holds Hearing as Optimi Health Advances MDMA Trial

As Elon Musk touts psychedelics for mental health and the FDA holds hearings, Optimi Health (OPTH) supplies commercial MDMA & psilocybin.read more...

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression PR Newswire VANCOUVER, BC, June 29, 2026 Optimi's 5mg psilocybin capsules are prescribed in...

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research PR Newswire VANCOUVER, BC, June 16, 2026 Two naturally derived finished drug products, at 1mg and 2mg, give research...

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial PR Newswire VANCOUVER, BC, June 10, 2026 The shipment of naturally derived psilocybin, comprising...

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development PR Newswire VANCOUVER, BC, June 8, 2026 Recent US executive order named ibogaine compounds among the psychedelic therapies...

Optimi Health (NASDAQ: OPTH) (CSE: OPTI) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising. Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN), a commercial-stage psychedelic pharmaceutical manufacturer, welcomed final recommendations from Australia’s Therapeutic Goods Administration regarding its Authorized Prescriber scheme for psilocybin and MDMA. The updated framework broadens eligible therapy teams, expands treatment settings beyond [&#8230;]

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia PR Newswire VANCOUVER, BC, May 29, 2026...

Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting

Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting PR Newswire VANCOUVER, BC, May 20, 2026 Common Shares to Trade on the Nasdaq Capital Market Under...

Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. It offers formulation, active pharmaceutical ingredients (APIs), and drug product manufacturing from preclinical stages to analysis and commercial distribution and It also offers botanical psilocybin and MDMA. The company was founded on May 27, 2020 and is headquartered in Squamish, Canada.

Optimi Health Corp

Neutral Sentiment

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits Polls

$OPTH Jeez, what’s going on here. Seems to be nothing but positive new reported recently. Just threw $100 at it to average down a bit.

$OPTH so obviously someone or group is plummeting this stock ahead of the investor meeting tomorrow.

Feed

News

Sentiment

Fundamentals

Info

OPTH Optimi Health Corp

Fundamentals

Latest OPTH News